{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:03:09Z","timestamp":1756191789568,"version":"3.41.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Castleman disease (CD) is a poorly understood lymphoproliferative disorder characterized by enlarged lymph nodes. The spectrum of differential diagnoses is wide, and it is hard to differentiate from other diseases. Cutaneous involvement of CD is rare, and studies that describe cutaneous dermatopathology of CD are scarce. The aim of this study was to collect case reports of CD with cutaneous manifestations and identify potential relevant histopathological features. We found that cases of CD with cutaneous manifestations often exhibited dermal lymphoid follicles with follicle center infiltration of lymphocytes and plasma cells. These dermal follicles also had regressive or atrophic germinal centers and were penetrated by hyalinized vessels. Patients with CD also consistently exhibited perivascular and deep dermal inflammatory infiltrate, primarily composed of lymphocytes and plasma cells. We intend to raise awareness of this rare entity and provide more histopathological information regarding its dermatological manifestations.<\/jats:p>","DOI":"10.1097\/dad.0000000000001971","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T18:00:51Z","timestamp":1621015251000},"page":"926-931","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Cutaneous Manifestations of Castleman Disease: Histopathological Characteristics and Review of Literature"],"prefix":"10.1097","volume":"43","author":[{"given":"Natalia A.","family":"Zapata-Salazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minerva","family":"G\u00f3mez-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Chavez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymphnode hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3109\/10428194.2014.953145","article-title":"Use of a claims database to characterize and estimate the incidence rate for Castleman disease","volume":"56","author":"Munshi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1634\/theoncologist.2010-0212","article-title":"Castleman's disease: from basic mechanisms to molecular therapeutics","volume":"16","author":"El-Osta","year":"2011","journal-title":"Oncologist"},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1158\/1535-7163.MCT-07-0256","article-title":"Cutaneous Castleman's disease responds to anti interleukin-6 treatment","volume":"6","author":"Ahmed","year":"2007","journal-title":"Mol Cancer Ther."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.clml.2011.07.004","article-title":"Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic Castleman disease: review and speculations about pathogenesis","volume":"11","author":"Haque","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.hoc.2017.09.004","article-title":"Pathology of castleman disease","volume":"32","author":"Wu","year":"2018","journal-title":"Hematol Oncol Clin North Am."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s12032-009-9355-0","article-title":"A retrospective study of unicentric and multicentric Castleman's disease: a report of 52 patients","volume":"27","author":"Ye","year":"2010","journal-title":"Med Oncol."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3109\/10428194.2011.574759","article-title":"Clinical dissection of multicentric Castleman disease","volume":"52","author":"Shin","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R10-20250616","first-page":"305","article-title":"Multicentric plasma cell variant Castleman's disease presenting with cutaneous vasculitis and pulmonary parenchymal involvement in a patient with ankylosing spondylitis: case report and review of the literature","volume":"66","author":"Wolf","year":"2011","journal-title":"Acta Clin Belg."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2340\/00015555-3253","article-title":"Cutaneous disorders associated with castleman's disease","volume":"99","author":"Kim","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.21037\/jtd.2019.10.73","article-title":"Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review","volume":"11","author":"Wojty\u015b","year":"2019","journal-title":"J Thorac Dis."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1684\/ejd.2019.3520","article-title":"Cutaneous vasculitis in HIV-associated Castleman's disease: a rare manifestation","volume":"29","author":"Kourkounti","year":"2019","journal-title":"Eur J Dermatol."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.prp.2012.09.006","article-title":"Cutaneous multicentric Castleman's disease mimicking IgG4-related disease","volume":"208","author":"Takeuchi","year":"2012","journal-title":"Pathol Res Pract."},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/sder.2000.8329","article-title":"Cutaneous lymphoid hyperplasias","volume":"19","author":"Gilliam","year":"2000","journal-title":"Semin Cutan Med Surg."},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/ijd.15043","article-title":"Cutaneous manifestations of Castleman disease","volume":"59","author":"Chavez-Alvarez","year":"2020","journal-title":"Int J Dermatol."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1365-4632.2009.04442.x","article-title":"An unusual case of cutaneous hyaline-vascular Castleman's disease with multicentric involvement and systemic symptoms","volume":"50","author":"Cardenas","year":"2011","journal-title":"Int J Dermatol."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/DAD.0b013e3181f498e2","article-title":"Cutaneous and systemic plasmacytosis showing histopathologic features as mixed-type Castleman disease: a case report","volume":"34","author":"Chen","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1159\/000456073","article-title":"Characterization of cutaneous plasmacytosis at different disease stages","volume":"232","author":"Hsiao","year":"2016","journal-title":"Dermatology"},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cas.13439","article-title":"Clinical characteristics and outcomes of Castleman disease: a multicenter study of 185 Chinese patients","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci."},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5045\/kjh.2012.47.3.163","article-title":"Castleman disease","volume":"47","author":"Saeed-Abdul-Rahman","year":"2012","journal-title":"Korean J Hematol."},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1053\/j.ajkd.2006.04.089","article-title":"Renal involvement in multicentric Castleman disease with glomeruloid hemangioma of skin and plasmacytoma","volume":"48","author":"Uthup","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"81","DOI":"10.17305\/bjbms.2017.1930","article-title":"TAFRO syndrome: new subtype of idiopathic multicentric Castleman disease","volume":"17","author":"Srkalovic","year":"2017","journal-title":"Bosn J Basic Med Sci."},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman's disease: a systematic literature review","volume":"3","author":"Liu","year":"2016","journal-title":"Lancet Haematol."},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0190-9622(91)70293-B","article-title":"Castleman's disease associated with pemphigus vulgaris","volume":"25","author":"Gili","year":"1991","journal-title":"J Am Acad Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T20:01:22Z","timestamp":1750104082000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001971","relation":{},"ISSN":["0193-1091"],"issn-type":[{"type":"print","value":"0193-1091"}],"subject":[],"published":{"date-parts":[[2021,5,11]]}}}